Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Director's Dealing 2016

Jul 5, 2016

65044_rns_2016-07-05_5ba7f272-7fe9-478b-a79a-6bb9da75f6e2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HOLISTA COLLTECH LIMITED
ARBN 094 515 992

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director
Date of last notice
Chan Heng Fai
26 May 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Date of change
No. of securities held prior to change
Class
Number acquired
Number disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation
Indirect
Global E Health Limited
Hengfai Business Development Pte Ltd
5 July 2016
32,514,935 Ordinary Fully Paid Shares
17,966,666 Warrants, 6 cents, expiring 17/12/2018
Ordinary Shares
1,200,000 Shares transferred from Hengfai Business
Development Pte Ltd to Global E Health Limited
1,200,000 Shares transferred from Hengfai Business
Development Pte Ltd to Global E Health Limited
Nil
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 32,514,935 Ordinary Fully Paid Shares
17,966,666 Warrants, 6 cents, expiring 17/12/2018
Nature of change
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment plan,
participation in buy-back
Off market transfer between Indirect holdings

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract -
Nature of interest -
Name of registered holder
(if issued securities)
-
Date of change -
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
-
Interest acquired -
Interest disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
-
Interest after change -

Part 3 –[+] Closed period

Part 3 –+Closed period Part 3 –+Closed period Part 3 –+Closed period Part 3 –+Closed period Part 3 –+Closed period Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
during a+closed peri
s required?
od where p rior written
If so, was pri
trade to proc
or writte n clearance rovided t o allow the N/A

eed durin

g this period
p
?
If prior writte
this provided
n clearan
?
ce was prov ided, on wh at date was N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011